FOCAL POINTS (Courageous Discourse)

FOCAL POINTS (Courageous Discourse)

Home
Podcast
Chat
Courage to Face COVID-19
Dr. McCullough
Archive
About

Share this post

FOCAL POINTS (Courageous Discourse)
FOCAL POINTS (Courageous Discourse)
BREAKING: HHS to Terminate 22 BARDA mRNA Shot Projects Worth $500M

BREAKING: HHS to Terminate 22 BARDA mRNA Shot Projects Worth $500M

RFK JR: "The data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu."

Nicolas Hulscher, MPH's avatar
Nicolas Hulscher, MPH
Aug 05, 2025
360

Share this post

FOCAL POINTS (Courageous Discourse)
FOCAL POINTS (Courageous Discourse)
BREAKING: HHS to Terminate 22 BARDA mRNA Shot Projects Worth $500M
96
70
Share
Cross-post from FOCAL POINTS (Courageous Discourse)
HHS Secretary Robert F. Kennedy, Jr. said "the move follows a scientific review showing mRNA shots fail to protect effectively against upper respiratory infections like COVID and flu" -
DG

by Nicolas Hulscher, MPH

In a major victory, the U.S. Department of Health and Human Services (HHS) announced it will wind down all mRNA injection development activities under BARDA — cancelling or de‑scoping 22 projects worth nearly $500 million.

HHS Secretary Robert F. Kennedy, Jr. said the move follows a scientific review showing mRNA shots fail to protect effectively against upper respiratory infections like COVID and flu, and that funding will now be redirected toward safer, broader platforms with proven durability against viral mutations.

However, one thing he failed to mention is that the mRNA injections caused catastrophic levels of injury and death:

The COVID Shot Catastrophe

Nicolas Hulscher, MPH
·
Jul 26
The COVID Shot Catastrophe

By Nicolas Hulscher, MPH

Read full story

Here are the key actions as outlined by HHS:

  • Cancellation of BARDA’s award to Moderna/UTMB for an mRNA-based H5N1 vaccine.

  • Termination of contracts with Emory University and Tiba Biotech.

  • De-scoping of mRNA-related work in existing contracts with Luminary Labs, ModeX, and Seqirus.

  • Rejection or cancellation of multiple pre-award solicitations, including proposals from Pfizer, Sanofi Pasteur, CSL Seqirus, Gritstone, and others, as part of BARDA’s Rapid Response Partnership Vehicle (RRPV) and VITAL Hub.

  • Restructuring of collaborations with DoD-JPEO, affecting nucleic acid-based vaccine projects with AAHI, AstraZeneca, and HDT Bio.

Some final-stage contracts will finish to preserve prior taxpayer investment, but no new mRNA-based projects will begin. BARDA Ventures has also been ordered to cease all mRNA equity investments.

Unfortunately, the FDA fast-tracked Bill Gates/BARDA-funded Arcturus Therapeutics replicon samRNA H5N1 "pandemic" bird flu injection (ARCT-2304) has NOT been canceled.

While we still need the immediate removal of COVID-19 mRNA shots from the market and accountability for the harm incurred, it’s nice to see some positive steps.


Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

www.mcculloughfnd.org

Please consider following both the McCullough Foundation and my personal account on X (formerly Twitter) for further content.

FOCAL POINTS (Courageous Discourse) is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

360

Share this post

FOCAL POINTS (Courageous Discourse)
FOCAL POINTS (Courageous Discourse)
BREAKING: HHS to Terminate 22 BARDA mRNA Shot Projects Worth $500M
96
70
Share

No posts

© 2025 Peter McCullough MD MPH
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share